Cellular And Molecular Gastroenterology And Hepatology SCIE

國(guó)際簡(jiǎn)稱：CELL MOL GASTROENTER 參考譯名：細(xì)胞和分子胃腸病學(xué)和肝病學(xué)

主要研究方向：Medicine-Gastroenterology 非預(yù)警期刊審稿周期： 19 Weeks

《細(xì)胞和分子胃腸病學(xué)和肝病學(xué)》(Cellular And Molecular Gastroenterology And Hepatology)是一本由Elsevier出版的以Medicine-Gastroenterology為研究特色的國(guó)際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本開放期刊，近三年沒有被列入預(yù)警名單。該期刊享有很高的科學(xué)聲譽(yù)，影響因子不斷增加，發(fā)行量也同樣高。

1區(qū) 中科院分區(qū)
Q1 JCR分區(qū)
112 年發(fā)文量
7.1 IF影響因子
開放是否OA
2015 創(chuàng)刊年份
8 issues/year 出版周期
English 出版語(yǔ)言

CMGH is the newest peer-reviewed journal published by the American Gastroenterological Association (AGA), joining Gastroenterology and Clinical Gastroenterology and Hepatology. The mission of CMGH is to publish impactful digestive biology research that ranges from mechanisms of normal function to pathobiology and covers a broad spectrum of themes in gastroenterology, hepatology, and pancreatology. The journal reports the latest advances in cell biology, immunology, physiology, microbiology, genetics, and neurobiology of gastrointestinal, hepatobiliary, and pancreatic health and disease. The research CMGH publishes is hypothesis driven, mechanistically novel, and appropriately designed and powered. Studies published in CMGH address important questions using tissues or cells from patients or animal models in order to make fundamental discoveries and translate them to human disease.

[ 查看全部 ]

投稿咨詢加急咨詢

Cellular And Molecular Gastroenterology And Hepatology期刊信息

ISSN：2352-345X
出版語(yǔ)言：English
是否OA：開放
E-ISSN：2352-345X
出版地區(qū)：UNITED STATES
是否預(yù)警：否
出版商：Elsevier
出版周期：8 issues/year
創(chuàng)刊時(shí)間：2015
開源占比：0.8422
Gold OA文章占比：75.23%
OA被引用占比：1
出版國(guó)人文章占比：0.04
出版撤稿占比：0
研究類文章占比：84.82%

Cellular And Molecular Gastroenterology And Hepatology CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

2.702

1.356

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Gastroenterology	Q1	10 / 167	94%
大類：Medicine 小類：Hepatology	Q1	11 / 82	87%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評(píng)論、會(huì)議論文、書籍章節(jié)和數(shù)據(jù)論文。

Cellular And Molecular Gastroenterology And Hepatology中科院評(píng)價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	1區(qū)	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學(xué)	2區(qū)

中科院 2022年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	1區(qū)	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學(xué)	2區(qū)

中科院 2021年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	1區(qū)	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學(xué)	2區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	1區(qū)	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學(xué)	2區(qū)

中科院 2021年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	1區(qū)	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學(xué)	2區(qū)

中科院 2020年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	1區(qū)	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學(xué)	2區(qū)

Cellular And Molecular Gastroenterology And Hepatology JCR評(píng)價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q1	15 / 143	89.9%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q1	16 / 143	89.16%

Cellular And Molecular Gastroenterology And Hepatology歷年數(shù)據(jù)統(tǒng)計(jì)

影響因子

中科院分區(qū)

Cellular And Molecular Gastroenterology And Hepatology中國(guó)學(xué)者發(fā)文選摘

1、Gut Microbiota-Derived Glutamine Attenuates Liver Ischemia/Reperfusion Injury via Macrophage Metabolic Reprogramming
Author: Lu, Tianfei; Li, Qing; Lin, Weiwei; Zhao, Xianzhe; Li, Fu; Ji, Jianmei; Zhang, Yu; Xu, Ning

Journal: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2023; Vol. 15, Issue 5, pp. 1255-1275. DOI: 10.1016/j.jcmgh.2023.01.004
2、Shp2 Deficiency in Kupffer Cells and Hepatocytes Aggravates Hepatocarcinogenesis by Recruiting Non-Kupffer Macrophages
Author: Du, Li; Ji, Yichun; Xin, Bing; Zhang, Jiemeng; Lu, Li-Chun; Glass, Christopher K.; Feng, Gen-Sheng

Journal: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2023; Vol. 15, Issue 6, pp. 1351-1369. DOI: 10.1016/j.jcmgh.2023.02.011
3、Mechanistic Insight and Clinical Implications of Ischemia/Reperfusion Injury Post Liver Transplantation
Author: Liu, Jiang; Man, Kwan

Journal: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2023; Vol. 15, Issue 6, pp. 1463-1474. DOI: 10.1016/j.jcmgh.2023.03.003
4、Single-cell Transcriptomics Reveals Early Molecular and Immune Alterations Underlying the Serrated Neoplasia Pathway Toward Colorectal Cancer
Author: Zhou, Yu-Jie; Lu, Xiao-Fan; Chen, Huimin; Wang, Xin-Yuan; Cheng, Wenxuan; Zhang, Qing-Wei; Chen, Jin-Nan; Wang, Xiao-Yi; Jin, Jing-Zheng; Yan, Fang-Rong; Chen, Haoyan; Li, Xiao-Bo

Journal: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2023; Vol. 15, Issue 2, pp. 393-424. DOI: 10.1016/j.jcmgh.2022.10.001
5、Sex Differences in Genomic Features of Hepatitis B-Associated Hepatocellular Carcinoma With Distinct Antitumor Immunity
Author: Xu, Chungui; Cheng, Shaoyan; Chen, Kun; Song, Qianqian; Liu, Chang; Fan, Chunsun; Zhang, Ruochan; Zhu, Qing; Wu, Zhiyuan; Wang, Yuting; Fan, Jian; Zheng, Hongwei; Lu, Lingling; Chen, Taoyang; Zhao, Hong; Jiao, Yuchen; Qu, Chunfeng

Journal: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2023; Vol. 15, Issue 2, pp. 327-354. DOI: 10.1016/j.jcmgh.2022.10.009
6、GLIS2 Prevents Hepatic Fibrosis by Competitively Binding HDAC3 to Inhibit Hepatic Stellate Cell Activation
Author: Zhang, Haoye; Zhou, Pengcheng; Xing, Wu; Chen, Limin; Zhou, Yangmei; Yang, Hui; Fu, Kangkang; Liu, Zhenguo

Journal: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2023; Vol. 15, Issue 2, pp. 355-372. DOI: 10.1016/j.jcmgh.2022.10.015
7、HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation
Author: Yuan, Jingsheng; Lv, Tao; Yang, Jian; Wu, Zhenru; Yan, Lvnan; Yang, Jiayin; Shi, Yujun; Jiang, Li

Journal: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2023; Vol. 15, Issue 2, pp. 307-325. DOI: 10.1016/j.jcmgh.2022.10.005
8、DCLK1 Suppresses Tumor-Specific Cytotoxic T Lymphocyte Function Through Recruitment of MDSCs via the CXCL1-CXCR2 Axis
Author: Yan, Rui; Li, Jianjian; Xiao, Zeru; Fan, Xiaona; Liu, Heshu; Xu, Ying; Sun, Ruya; Liu, Jian; Yao, Jiannan; An, Guangyu; Shi, Yan; Ge, Yang

Journal: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2023; Vol. 15, Issue 2, pp. 463-485. DOI: 10.1016/j.jcmgh.2022.10.013